Company news

Genetic Signatures Ltd. news in 2024

Genetic Signatures Ltd.'s news releases, calls and decks from 2024, newest first.

View company

$5m R&D Tax Incentive Received

November 21, 2024

2024 AGM Chairman's Address and CEO Presentation

November 19, 2024

Appendix 4E and Annual Report

August 30, 2024

Despatch Of Retail Entitlement Offer Booklet

June 12, 2024

Completion of Institutional Entitlement Offer and Placement

June 5, 2024

FDA Clearance and Capital Raising Presentation

June 4, 2024

Genetic Signatures Announces $30 Million Capital Raising

June 3, 2024

Genetic Signatures Appoints Allison Rossiter As CEO

June 3, 2024

FDA Clearance For Gastrointestinal Parasite Detection Kit

June 3, 2024

Trading Halt

May 31, 2024

Decision to Cease Development of US Respiratory Product

May 26, 2024

Leadership Transition at Genetic Signatures

April 29, 2024

TGA authorises supply of updated Respiratory Detection Kit

April 21, 2024

1H 24 Market Update

February 21, 2024

Genetic Signatures Rights Issue Offer Booklet

January 1, 2024

Decks in 2024